UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 7, 2006
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other
jurisdiction of
incorporation or
organization)
| |
|
|
1-07151
(Commission File
Number)
|
|
31-0595760
(I.R.S. Employer
Identification No.) |
1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)
(510) 271-7000
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2.)
o Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers
On March 7, 2006, The Clorox Company (the “Company”) announced that the Board of Directors
(the “Board”) of the Company named Robert W. Matschullat as interim chairman and interim chief
executive officer. The appointment is effective immediately and follows the hospitalization of
chairman and chief executive officer Jerry Johnston. In connection with his appointment as interim
chairman and interim chief executive officer, Mr. Matschullat stepped down from his role as
presiding director and as a member of the audit committee and chair of the nominating and
governance committee. The Board appointed current director Gary G. Michael as interim presiding
director and current director Daniel Boggan, Jr. as interim chair of the nominating and governance
committee to fill the vacancies temporarily created by Mr. Matschullat’s appointment as interim chairman and
interim chief executive officer.
At this time, the
terms of Mr. Matschullat’s interim employment arrangement with the Company have not
been determined. The Company will file an amendment to this Form 8-K when such arrangement has
been determined.
A copy of the press release announcing the appointment of Mr. Matschullat is filed hereto as
Exhibit 99.1 and is incorporated herein in its entirety.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
| |
|
|
| Exhibit |
|
Description |
99.1
|
|
Press release dated March 7, 2006. |